Agronomics Limited Director/PDMR Shareholding (3764U)

TIDMANIC

RNS Number : 3764U

Agronomics Limited

28 March 2023

28(th) March 2023

Agronomics Limited

("Agronomics" or the "Company")

Directors' Dealings

Agronomics, the leading listed company focused on the field of cellular agriculture, is pleased to confirm that Jim Mellon, Executive Director, a PDMR, purchased an additional 666,001 ordinary shares in the Company ("Ordinary Shares") at an average price of 10.49 pence per share on 27(th) March 2023.

This is further to the 27(th) March 2023 announcement of Jim Mellon's purchase of 50,000 ordinary shares at 10 pence per share.

Following these transactions, Jim Mellon is interested in a total of 154,161,364 Ordinary Shares, of which 139,448,621 are held by Galloway Limited and 12,722,782 are held by Shellbay Investments Limited, companies which are both indirectly wholly owned by Jim Mellon, and 1,989,961 Ordinary Shares are held directly by Mr Mellon.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

About Agronomics

Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and be fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.

Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists' claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5 .

AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US $1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital to build out manufacturing facilities. Funding in the field of cellular agriculture is accelerating, however, still, less than US$ 5 billion has been invested worldwide since the industry's inception in 2016.

For further information please contact:

 
       Agronomics         Beaumont     Canaccord        Cenkos        Peterhouse           TB Cardew 
         Limited           Cornish      Genuity        Securities       Capital 
                           Limited      Limited           Plc           Limited 
      The Company          Nomad         Joint           Joint           Joint          Public Relations 
                                         Broker          Broker          Broker 
                        ==========  ==============  =============  ===============  ======================== 
      Richard Reed         Roland       Andrew           Giles       Lucy Williams         Ed Orlebar 
       Denham Eke          Cornish       Potts          Balleny         Charles          Alistair Walker 
                            James        Harry          Michael        Goodfellow 
                           Biddle         Rees          Johnson 
                                       Alex Aylen 
                                         (Head 
                                      of Equities) 
                        ==========  ==============  =============  ===============  ======================== 
                                                                                        [phone] 
                                                                                              0777 
      +44 (0) 1624        +44 (0)       +44 (0)         +44 (0)         +44 (0)           +44 (0) 7738 
         639396            207 628      207 523         207 397         207 469              724 630 
   [e-mail]       3396          8000            8900            0936       [e-mail] 
                        ==========  ==============  =============  ===============  ======================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFFDVVIDFIV

(END) Dow Jones Newswires

March 28, 2023 02:00 ET (06:00 GMT)